Campari Stock (CPR): Price, the Hunt Turnaround and Board Talking Points

Davide Campari-Milano N.V. (Euronext Milan: CPR) is one of the most-discussed consumer names on Italian investor forums, and it is easy to see why. The group behind Campari, Aperol, Espolòn and — since 2024 — Courvoisier cognac is a branded-spirits leader that has spent the last two years going through a leadership shake-up, a debt-heavy acquisition and a full restructuring at the same time. That combination keeps threads busy: retail investors want to know whether the turnaround is working, and whether the family-controlled structure changes how they should read the numbers.

Campari has been incorporated in the Netherlands since its 2020 cross-border redomicile, while operations remain headquartered in Sesto San Giovanni, near Milan. The stock is a constituent of the FTSE MIB, Borsa Italiana's blue-chip index. For the record, Campari is actively trading — not suspended, not insolvent, not delisted — and reduced its net debt during 2025.

Price context: what forum users actually track

This page does not publish a live quote or a price target. What matters for the "azioni Campari forum" conversation is the fundamentals that move sentiment around each earnings date. In its FY2025 results (reported 4 March 2026), Campari posted net sales of €3,051M (−0.6% reported, +2.4% organic), adjusted EBIT of €637M (20.9% of sales, +5.3%), and net debt cut to €1,958M, or 2.5x EBITDA — down from a peak of 3.6x on 30 September 2024. The board also proposed a dividend up 54%. Those are the reference numbers most forum posts cite when they debate whether the shares are cheap or fully valued.

Board talking points: what investors are discussing

These are the recurring storylines on Italian forums — framed as what people debate, not as predictions.

• Can the Hunt turnaround restore growth? After a turbulent 2024, industry veteran Simon Hunt (ex-William Grant & Sons) became CEO effective 15 January 2025. His plan targets roughly 200 basis points of structural cost savings by 2027, alongside about 500 job cuts (~10% of the ~5,000 workforce, with roughly 100 in Italy). Investors debate whether cost discipline can translate into a genuine growth restart.
• Did Campari overpay for Courvoisier? The $1.32B Courvoisier cognac acquisition (2024) landed just as cognac demand softened, China trade barriers hardened and US-tariff risk rose. Q3 2024 operating profit fell 18.2%, and the cognac exposure is the single most relitigated call on the forums.
• A +54% dividend against a muted top line. Is the sharp dividend increase a confidence signal from the board, or a capital-allocation question mark while sales are roughly flat? Both readings appear in the threads.
• Family control as a governance backdrop. Lagfin S.C.A. (the Luxembourg holding of the Garavoglia family) holds 51% of equity but roughly 81.6% of voting rights through enhanced multiple-voting shares; Luca Garavoglia has chaired the company since 1994. Retail investors weigh what that concentration means for minority holders.
• The settled Lagfin tax matter. This is a holding-company issue, not a case against Campari's operating business. In October 2024 the Guardia di Finanza seized €1.29B of Lagfin's Campari shares over an alleged unpaid exit tax tied to the 2020 cross-border merger; the matter was settled with the Italian Revenue Agency in December 2024 for €405M payable over four years, and Lagfin regained control of roughly 214M seized shares (announced December 2025). Forum users treat it as a resolved overhang, at the Lagfin level.

Outlook: catalysts and dates to watch

The qualitative outlook is a margin-recovery story. Management's stated path runs toward the 2027 structural-savings target, with the FY2025 report (4 March 2026) already showing net debt back to 2.5x EBITDA and organic sales up 2.4%. The 2026-03-04 AGM reshaped the board after the resignations of Alessandra Garavoglia, Robert Kunze-Concewitz and Paolo Marchesini, so governance continuity is itself a watch-item. US-tariff exposure and the pace of the cognac-market recovery are the external variables the company itself flags. None of this is a forecast — it is the catalyst calendar investors line up against.

The forum crowd and the crypto crossover

Italian retail investors who research single-stock stories like Campari on forums increasingly follow crypto markets in the same session — the two audiences overlap heavily. If that describes you, it is worth understanding how a regulated-style venue handles crypto trading before you commit capital.

WEEX is a crypto exchange built around crypto futures, with deep liquidity on major pairs and both spot and derivatives access. To be clear: Campari shares do not trade on WEEX — CPR is an equity listed on Euronext Milan. WEEX is where you would trade crypto (for example BTC or ETH perpetual futures), not Italian equities. If you also follow the most crypto-linked corners of the equity market, our Italian guide to NVIDIA covers a name at the centre of that conversation.

For more heavily-discussed Borsa Italiana names, see our forum pages on Ferrari and Amplifon.

Not investment advice. This article is for information only and does not constitute a recommendation to buy or sell any security or crypto asset. Figures are drawn from Campari's own disclosures on the dates cited and may since have changed. Crypto and derivatives trading involves a high risk of loss. Do your own research and consider your risk tolerance before investing.